Leukocyte protein tyrosine kinases: Potential targets for drug discovery

Annual Review of Immunology

Volumn 15, Issue , 1997, Pages 371-404

  Bolen, Joseph B ^a   Brugge, Joan S ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

leukocytes; phosphorylation; signal transduction; tyrosine kinases

Indexed keywords

CYTOKINE RECEPTOR; PROTEIN TYROSINE KINASE;

ANTIGEN RECOGNITION; DRUG TARGETING; ENZYME ANALYSIS; ENZYME SUBSTRATE COMPLEX; IMMUNOPHARMACOLOGY; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; LEUKOCYTES; MODELS, BIOLOGICAL; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 0030891168     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.15.1.371     Document Type: Review

References (8)

1. Brown MT, Cooper JA. 1996. Regulation, substrates and functions of Src. BBA Rev. Cancer In press
2. Desiderio S, Siliciano JD. 1994. The Itk/Btk/Tec family of protein tyrosine kinases. Chem. Immunol. 59:191-210
3. Rawlings DJ, Witte ON. 1995. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function. Sem. Immunol. 7:237-46
4. Finbloom DS, Lamer AC. 1995. Regulation of the JAK/STAT signalling pathway. Cell. Signal. 8:739-45
5. Pendergast AM. 1996. Nuclear tyrosine kinases: from Abl to WEE1. Curr. Op. Cell. Biol. 8:174-81
6. Hardie G, Hanks S, eds. 1995. The Protein Kinase Facts Book. London: Academic
7. Pawson T, Gish GD. 1992. SH2 and SH3 domains: from structure to function. Cell 70:694-704
8. Feng S, Chen JK, Yu H, Simon JA, Schreiber SL. 1994. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266:1241-47